Astrazeneca (NYSE:AZN)
AstraZeneca, the pharmaceutical giant born from the merger of Astra AB and Zeneca PLC, has established itself as one of the world leaders in the sector with around 100,000 employees dedicated to the research, development and marketing of pharmaceutical products. The group presents solid financial indicators, with an attractive yield and a generous dividend distribution policy, although investors should be cautious due to the relative youth of its successive dividend increases.
Astrazeneca (NYSE:AZN) Read More »